Tribeca is a neurology-focused medical affairs consulting company that helps pharmaceutical and biotechnology start-ups turn complex science into clear, actionable insight. Our expertise spans Alzheimer’s disease, Parkinson’s disease, epilepsy, and other neurological disorders.

We provide end-to-end support including conference coverage and reporting, medical writing, and medical translation from English to Spanish. Acting as an extension of your team, we fill critical gaps for companies that are lean, growing, or scaling medical affairs capabilities.

Our strength lies in translating scientific data for diverse audiences—from scientists and clinicians to sales, marketing, and the broader public—across languages and regions. With a global perspective and a practical approach, we help emerging companies communicate science clearly, efficiently, and with impact.

Tribeca was founded by David Cantu, PhD. After receiving his doctorate in Neuroscience, he completed his post-doctoral training at Tufts University School of Medicine in Boston, MA. He has over 10 years of Medical Affairs experience in the pharmaceutical industry.